☆ 4.7 Letter

FLT3 pathway is a potential therapeutic target for PRC2-mutated T-cell acute lymphoblastic leukemia

BLOOD (2018)

Get Full Text
Add to Collection

Journal

BLOOD
Volume 132, Issue 23, Pages 2520-2524

Publisher

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2018-04-845628

Keywords

-

Categories

Hematology

Funding

  1. Ministry of Science and Technology of China [2016YFA0100600]
  2. Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences grants [2016-I2M-1-002, 2017-I2M-1-015, 2016-I2M-1-017, 2017-I2M-3-018, 2017-I2M-3-009]
  3. National Nature Science Foundation of China [81421002, 81470339, 81400137, 81770175, 81672010, 31600705]
  4. Peking Union Medical College Youth Fund [3332016091]
  5. nonprofit Central Research Institute Fund of the Chinese Academy of Medical Sciences [2016ZX310184-1]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.